李苞芳,刘茜

• 1:浙江中医药大学
• 2:浙江省杭州养和医院

摘要(Abstract)：

<正>糖尿病肾病(DN)属糖尿病微血管病变,是糖尿病临床常见的严重并发症之一。在糖尿病患者中DN的发生率约47.66%,其中早期DN发生率约34.11%。其临床特征为持续性尿蛋白,随着病情的发展及恶化,出现氮质血症,最终导致慢性肾功能不全。近年来,中西医治疗DN的研究积累了一些经验,并显示

关键词(KeyWords)： 糖尿病;肾病;中西医治疗;综述

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 李苞芳,刘茜

参考文献(References)：

• [1]陈筱云,赵莉娟.从瘀论治糖尿病肾病[J].中国中医基础医学杂志,2002,8(7):53-54.
• [2]杨文军,赵孔华.脾肾气机升降失常与糖尿病肾病关系探讨[J].山东中医药大学学报,2005,29(3):188-189.
• [3]唐咸玉.范冠杰教授治疗糖尿病的经验[J].中医药学刊,2006,24(2):215-216.
• [4]陈潮.益气温阳为主治疗糖尿病肾病水肿60例疗效观察[J].新中医,2008,40(5):21-22.
• [5]许珍.疏肝补肾益气中药对早期糖尿病肾病患者ET-1及CGRP的影响[J].中国中西医结合肾病杂志,2004,5(10):609-610.
• [6]凌青,徐德颐.中药益气养阴治疗糖尿病肾病34例疗效观察[J].黑龙江中医药,2006,4(2):6-8.
• [7]周硕果.温肾健脾法治疗早期糖尿病肾病的临床观察[J].四川中医,2009,27(1):74-75.
• [8]江映红.中西医结合治疗糖尿病肾病30例分析[J].中国医药学报,2003,15(1):78.
• [9]郑庆媛.糖尿病肾病辨证分型论治[J].实用中医内科杂志,2003,17(2):72-72.
• [10]王国芝,张莉,屈云,等.糖尿病肾病的中西医结合治疗的临床研究[J].现代中医药,2003,4:36-38.
• [11]王耀献,王翚.糖尿病肾病的中医分型辨证论治[J].糖尿病新世界,2005,8(4):22.
• [12]刘小菊,叶玉珠.补阳还五汤加减治疗早期糖尿病肾病58例[J].浙江中医药大学学报,2009,1(1):75.
• [13]李亚文,杨焱,陈凤娇,等.血府逐瘀汤加减治疗糖尿病肾病40例疗效观察[J].中国现代药物应用,2009,3(3):95-96.
• [14]杨华.降糖保肾胶囊治疗糖尿病肾病100例临床研究[J].云南中医中药杂志,2007,28(3):10-11.
• [15]董华山.益肾通络活血汤治疗糖尿病肾病30例[J].浙江中医杂志,2009,44(3):204-205.
• [16]吴波,韩萍,刘英敏.金纳多治疗糖尿病早期肾病的临床疗效观察[J].辽宁中药与临床,2002,5(3):128-129.
• [17]杨小红,张伟程,李兰铮.火把花根片治疗糖尿病肾病的疗效观察[J].中华临床医学杂志,2004,6(3):75-76.
• [18]江彤.灯盏花、黄芪降低2型糖尿病患者微量白蛋白尿的临床观察[J].陕西中医杂志,2002,31(9):830-831.
• [19]Heidland A,Sebekova K,Schinzel R.Advanced glycation end productsand the progressive course of renal diease[J].Am J kidney Dis,2001,38(suppl):100-106.
• [20]李兴,赵宝珍.非酶糖化与糖尿病慢性并发症[J].医学综述,1999,5(9):412.
• [21]Hodgkinson A D,Millwand B A,Demaine A G.Polymorphism oftheglucose transporter(GLUT1)gene are associated with diabetic-nephropathy[J].Kiney Int,2001,59(3):985.
• [22]Okada S,Shikata K.Intercellular adhesion molecule-1 deficientmice are resistant against renal injury after induction of diabtes[J].Di-abetes,2003,52(10):2586.
• [23]Melin J,Hellberg O,Larsson E,et al.Protective effect of insulin on is-chemic renal injury in diabetes mellitus[J].Kidney Int,2002,61(4):1383-1392.
• [24]Veelken R,Delles C,Hilgers K F,et al.Outcome survey inunselected hy-pertensive patients with type 2 diabetes mellituseffects of inhibition[J].AmJHypertens,2001,14(7):672-678.
• [25]Kuriyama S,Tomonari H,Ohtsuka Y,et al.Salt Mtake and the progressionofchronicrenaldiseases[J].NipponJinzoGakkaiShi,2003,45(4):367-371.
• [26]Kim S L,Han D C,Lee H B.Lovastatin inhibits transforming growthfactor-β,expression in diabetic rat glomeruli and cultured ratmesan-gial cells[J].J Am Soc Nephrol,2000,11(1):80-87.
• [27]Itoh Y,Yasui T,Kakizawa H,et al.The therapeutic effect of lipo PGE1on diabetic neuropathy-changes in endothelin and various angiopathicfactors[J].Prostaglandins other Lipid Mediat,2001,66(3):221-234.
• [28]Hill C,Flyvbjerg A,Rasch R,et al.Transforming growth factor-beta 2antibody attenuates fibrosis in the experimental diabetic ratkidney[J].J Endocrinol,2001,170(3):647-651.
• [29]Arakaawa K,Ishihara T,Oku A,et al.Improved diabeetic syndrome inC57BL/KsJ-db/db mice by oral administration of the Na+-glucose co-transporter T-1095[J].Br J Pharmacol,2001,132(2):578-586.